Teratoma future or investigational therapies: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 24: | Line 24: | ||
[[Category:Pathology]] | [[Category:Pathology]] | ||
[[Category:Surgery]] | [[Category:Surgery]] | ||
[[Category:Types of cancer]] | [[Category:Types of cancer]] | ||
[[Category:Rare diseases]] | [[Category:Rare diseases]] | ||
[[Category:Pediatric cancers]] | [[Category:Pediatric cancers]] | ||
[[Category:Endocrinology]] | [[Category:Endocrinology]] | ||
Revision as of 16:57, 30 August 2015
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
|
Teratoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Teratoma future or investigational therapies On the Web |
|
American Roentgen Ray Society Images of Teratoma future or investigational therapies |
|
Risk calculators and risk factors for Teratoma future or investigational therapies |
Overview
Use in basic research
In light of the ethical issues surrounding the source of human stem cells, teratomas are being looked at as an alternative source for research since they lack the potential to grow into functional human beings.
Clinical trials
There are now (2007) two clinical trials in progress that address germ cell tumors, both of which include teratomas.[1][2]
References
- ↑ GCT1P1 Protocol / Clinical Study: Pilot study of Cisplatin, Etoposide, Bleomycin and Escalating Dose Cyclophosphamide Therapy for Children with High-Risk Malignant Germ Cell Tumors
- ↑ GCT132 Protocol / Clinical Study: A Phase III Study of Reduced Therapy in the Treatment of Children with Low and Intermediate Risk Extracranial Germ Cell Tumors (AGCT0132)